Welcome to the
Pascoal Lab
About the
Lab
Our lab is interested in the quantification of brain pathophysiology in patients with Alzheimer’s disease (AD) and related dementias as well as in the validation of therapies capable of modifying the course of these diseases producing an enduring disease-modifying and clinically relevant effect. This involves the validation of positron emission tomography (PET) and fluid biomarker techniques capable of measuring these brain pathologies and monitoring their progression.
Recent
Publications
Alzheimer’s & Dementia
Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer’s disease
Alzheimer’s & Dementia
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals
Nature Medicine
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Stay Tuned
News
Funding
Affiliations




Funding


Affiliations

